IP Library Patent Application 15458185
Patent Application
App. No. 15/458,185

Neuromuscular Junction: NMJ-ON-CHIP

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/458,185
Abstract

The invention relates to culturing motor neuron cells together with skeletal muscle cells in a fluidic device under conditions whereby the interaction of these cells mimic the structure and function of the neuromuscular junction (NMJ) providing a NMJ-on-chip. Good viability, formation of myo-fibers and function of skeletal muscle cells on fluidic chips allow for measurements of muscle cell contractions. Embodiments of motor neurons co-cultures with contractile myo-fibers are contemplated for use with modeling diseases affecting NMJ's, e.g. Amyotrophic lateral sclerosis (ALS).

Claims (20)

1 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a membrane, said membrane comprising a top surface and a bottom surface; b) seeding induced motor neuron cells on said top surface and skeletal muscle cells on said bottom surface so as to create seeded cells; c) exposing said seeded cells to a flow of culture media for a period of time; and d) culturing said seeded cells under conditions such that a neuromuscular junction forms within said microfluidic device.

2 . The method of claim 1 , wherein said skeletal muscle cells are induced to differentiate.

3 . The method of claim 2 , wherein said skeletal muscle cells form contractile tissue.

4 . The method of claim 2 , wherein said skeletal muscle cells form polynucleated myo-fibers.

5 . The method of claim 1 , wherein said seeded cells are cultured for more than ten days.

6 . The method of claim 1 , wherein said induced motor neuron cells are derived from induced pluripotent stem cells from a human.

7 . The method of claim 6 , wherein said human is diagnosed with a CNS disorder.

8 . The method of claim 1 , further comprising the step of e) assessing the health and/or integrity of the neuromuscular junction.

9 . The method of claim 1 , further comprising the step of e) electrically stimulating said motor neurons and/or said skeletal muscle cells.

10 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a channel; b) seeding skeletal muscle cells into said channel; c) inducing said skeletal muscle cells to differentiate; and d) detecting myo-fiber formation.

11 . The method of claim 10 , wherein said detecting of myo-fiber formation comprises detecting myo-fiber contractions.

12 . The method of claim 10 , wherein said seeded cells are exposed to a flow of culture media for a period of time.

13 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a patterned surface and a gel, b) seeding induced motor neuron cells on said patterned surface and skeletal muscle cells on said gel.

14 . The method of claim 13 , further comprising c) detecting myo-fiber formation by said skeletal muscle cells.

15 . The method of claim 14 , wherein said detecting of myo-fiber formation comprises detecting myo-fiber contractions.

16 . The method of claim 13 , wherein said skeletal muscle cells and/or said motor neurons are exposed to a flow of culture media for a period of time.

17 . A microfluidic device comprising a) a membrane, said membrane comprising a top surface and a bottom surface; and b) induced motor neuron cells on said top surface and skeletal muscle cells on said bottom surface.

18 . The device of claim 17 , wherein said induced motor neuron cells are derived from induced pluripotent stem cells from a human.

19 . The device of claim 18 , wherein said human is diagnosed with a CNS disorder.

20 . The device of claim 19 , wherein said CNS disorder is ALS.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION SERIAL NUMBER 15458158 PREVIOUSLY RECORDED AT REEL: 045706 FRAME: 0453. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded May 7, 2018
From: KERNS, S. JORDAN; WEN, NORMAN; HAMILTON, GERALDINE; HINOJOSA, CHRISTOPHER; FRASER, JACOB; KARALIS, CATHERINE; NAWROTH, JANNA; SAREEN, DHRUV; KAUS, ANJOSCHA; MANDEFRO, BERHAN; PARK, HYOUNG SHIN; KUJALA, VILLE
To: EMULATE, INC.; CEDARS-SINAI MEDICAL CENTER
Reel/Frame 046084/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: KERNS, S. JORDAN; WEN, NORMAN; HAMILTON, GERALDINE; HINOJOSA, CHRISTOPHER; FRASER, JACOB; KARALIS, CATHERINE; NAWROTH, JANNA; SAREEN, DHRUV; KAUS, ANJOSCHA; MANDEFRO, BERHAN; PARK, HYOUNG SHIN; KUJALA, VILLE
To: EMULATE, INC.; CEDARS-SINAI MEDICAL CENTER
Reel/Frame 045706/0453 →